Mediclinic Southern Africa is a private hospital group operating in South Africa and Namibia focused on providing acute care,
specialist-orientated, multi-disciplinary hospital services and related service offerings. We place
science at the heart of our care process by striving to provide evidence-based care of the highest
standard. The group currently operates 48 private hospitals (excluding four day clinics) throughout
South Africa and three hospitals in Namibia with more than 8 200 beds in total.
Mediclinic Southern Africa is a wholly owned subsidiary of the international private healthcare group Mediclinic International
PLC, listed on the LSE (London Stock Exchange) with a secondary listing on the JSE (Johannesburg
Stock Exchange) and the NSX (Namibian Stock Exchange).
Mediclinic International currently has three operating divisions - Mediclinic Southern Africa which operates 51 private hospitals
and four day clinics throughout South Africa and Namibia; Hirslanden operates 18 private acute care
facilities and four clinics in Switzerland with more than 1 800 inpatient beds and Mediclinic Middle
East which operates seven hospitals and 22 clinics with more than 700 inpatient beds in the United Arab
The Group also holds a minority interest of 29.9% in Spire Healthcare Group PLC, a leading private hospital group in the
United Kingdom and also listed on the LSE.